Skip to content
6-K

Foreign Interim / Material

NIGHTSTAR THERAPEUTICS PLC

0001564590-18-021845

← back to feed
Filed
Aug 15, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex Q2 2018 · Jun 30, 2018 $163K
Capex Q2 2018 · Jun 30, 2017 $55K
Operating Cash Flow Q2 2018 · Jun 30, 2018 −$24.16M
Operating Cash Flow Q2 2018 · Jun 30, 2017 −$5.7M
Cash And Equivalents Q2 2018 · Jun 30, 2018 $41.58M
Cash And Equivalents Q2 2018 · Dec 31, 2017 $129.4M
Stockholders Equity Q2 2018 · Jun 30, 2018 $109.07M
Stockholders Equity Q2 2018 · Dec 31, 2017 $125.81M
Current Liabilities Q2 2018 · Jun 30, 2018 $12.12M
Current Liabilities Q2 2018 · Dec 31, 2017 $9.39M
Total Liabilities Q2 2018 · Jun 30, 2018 $12.12M
Total Liabilities Q2 2018 · Dec 31, 2017 $9.39M
Current Assets Q2 2018 · Jun 30, 2018 $120.59M
Current Assets Q2 2018 · Dec 31, 2017 $134.84M
Total Assets Q2 2018 · Jun 30, 2018 $121.19M
Total Assets Q2 2018 · Dec 31, 2017 $135.2M
Sga Expense Q2 2018 · Jun 30, 2018 $3.32M
Sga Expense Q2 2018 · Jun 30, 2018 $6.1M
Sga Expense Q2 2018 · Jun 30, 2017 $677K
Sga Expense Q2 2018 · Jun 30, 2017 $1.41M
Rd Expense Q2 2018 · Jun 30, 2018 $8.05M
Rd Expense Q2 2018 · Jun 30, 2018 $14.12M
Rd Expense Q2 2018 · Jun 30, 2017 $3.54M
Rd Expense Q2 2018 · Jun 30, 2017 $6.29M
Net Income Q2 2018 · Jun 30, 2018 −$8.1M
Net Income Q2 2018 · Jun 30, 2018 −$22.45M
Net Income Q2 2018 · Jun 30, 2017 −$4.22M
Net Income Q2 2018 · Jun 30, 2017 −$7.69M